CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 63.8 CNY -0.13% Market Closed
Market Cap: 7.3B CNY
Have any thoughts about
CanSino Biologics Inc?
Write Note

Gross Margin
CanSino Biologics Inc

67.7%
Current
36%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.7%
=
Gross Profit
506.8m
/
Revenue
748.5m

Gross Margin Across Competitors

Country CN
Market Cap 7.3B CNY
Gross Margin
68%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 749.7B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 372B USD
Gross Margin
69%
Country US
Market Cap 257.3B USD
Gross Margin
77%
Country CH
Market Cap 201.7B CHF
Gross Margin
73%
Country UK
Market Cap 163B GBP
Gross Margin
82%
Country CH
Market Cap 179.6B CHF
Gross Margin
75%
Country US
Market Cap 146B USD
Gross Margin
71%
No Stocks Found

CanSino Biologics Inc
Glance View

Market Cap
7.3B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
66.95 CNY
Undervaluation 5%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
67.7%
=
Gross Profit
506.8m
/
Revenue
748.5m
What is the Gross Margin of CanSino Biologics Inc?

Based on CanSino Biologics Inc's most recent financial statements, the company has Gross Margin of 67.7%.